Overexpression of DDX43 Mediates MEK Inhibitor Resistance through RAS Upregulation in Uveal Melanoma Cells
Open Access
- 1 August 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 13 (8) , 2073-2080
Abstract
The majority of uveal melanomas carry oncogenic mutations in the G proteins GNAQ and GNA11, with consequent activation of the MAPK pathway. Selective MEK inhibitors, such as selumetinib, have shown clinical benefit in uveal melanoma. However, mechanisms of drug resistance limit their efficacy in some patients. Analysis of MEK inhibitor–resistant uveal melanoma cell lines revealed the induction of RAS protein expression and activity. This effect was mediated by the RNA helicase DDX43, which was remarkably overexpressed in these cells. Depletion of DDX43 in MEK inhibitor–resistant cells decreased RAS proteins and inhibited ERK and AKT pathways. On the contrary, ectopic expression of DDX43 in parental uveal melanoma cells induced RAS protein levels and rendered cells resistant to MEK inhibition. Similar to DDX43 depletion, downregulation of KRAS, HRAS, and NRAS inhibited downstream pathways in the resistant cells, overcoming mutant GNAQ signaling. We also analyzed the expression of DDX43 in liver metastases of patients with uveal melanoma by RT-PCR, and found a significant overexpression of DDX43 in patients who did not benefit from selumetinib therapy. In conclusion, DDX43 induces RAS protein expression and signaling, mediating a novel mechanism of MEK inhibitor resistance. The detection of DDX43 in patients with uveal melanoma could lead to more targeted therapies for this disease. Mol Cancer Ther; 13(8); 2073–80. ©2014 AACR.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in VivoJournal of Biological Chemistry, 2012
- Genetic and molecular characterization of uveal melanoma cell linesPigment Cell & Melanoma Research, 2012
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E MutationScience Signaling, 2010
- DEAD‐box proteins as RNA helicases and chaperonesWIREs RNA, 2010
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- RNA‐binding proteins and post‐transcriptional gene regulationFEBS Letters, 2008
- DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulationNucleic Acids Research, 2006
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994